Skip to content
AwardedPRTGoods€436,809

IMUNOMODULADORES - NIVOLUMAB - 3º TRIMESTRE

Published
Published 4 September 2025

Overview

IMUNOMODULADORES - NIVOLUMAB - 3º TRIMESTRE

Key details

Country
PRT
Status
Awarded
Category
Goods
Estimated value
€436,809
Procedure
Selective
Published
4 September 2025
Classification (CPV)
Pharmaceutical productsVarious medicinal products

Award outcome

Awarded value
€436,809
Award date
7 August 2025
Contract period
— → 5 November 2025
Winner
  • BRISTOL MYERS SQUIBB FARMACEUTICA PORTUGUESA,S A

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    8 September 2025

  2. Contract Award Notice

    4 September 2025

Contracting authority

  • Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)

    Procuring entity

    Funchal, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: IMUNOMODULADORES - NIVOLUMAB - 3º TRIMESTRE — won by BRISTOL MYERS SQUIBB FARMACEUTICA PORTUGUESA,S A — Skim